prevalence of vaginal candidiasis with different methods of contraception

This study included 110 women classified into 3 groups; 30 using oral pills, 40 using intrauterine device [lUD] and 40 using no method of contraception as a control group. High vaginal swabs were taken; smears prepared, stained with gram and cultures made on Sabouraud Dextrose agar with chloramphenicol. Isolated yeast colonies were identified by germ tube formation test, API-20 c system and morphology on cornmeal tween 80 agar. Candida species have been isolated in 22. 5% of IUD users group, 20% in pins users group and 15% in the control group. Candida albicans could be isolated in 68.2% out of 22 isolates from all cases, C. glabrata in 27.3% and C. krusei in 4.5%. Candida albicans found to be the most prevalent species in the studied groups of women

Doxycycline treatment in mycoplasma and ureaplasma urinary tract infections

Mycoplasma hominis [M. hominis] and Urea plasma urealyticum [U. urealyticum] were documented to play a significant role in recurrent urinary tract infections [UTI] in Egyptian patients especially when associated with urinary schistosomiasis. Doxycycline is the drug of choice used to treat these infections at TBRI [100 mgtwice daily for 2 weeks] and this study was conducted to evaluate its efficacy. Fifty six patients with M. hominis and/or U. urealyticum UTI were included and classified into two groups according to association with urinary schistosomiasis. Cure rates of 39.4% and 34.8% were achieved after one course of treatment in group [I] [schistosomal] and in group [II] [non-schistosomal] patients respectively. Higher rates were achieved after a second course of doxycycline in resistant cases [88% and 91% respectively] Test-of-cure cultures obtained 10-15 days after completion of therapy showed treatment failure in only 6 patients [10.9%], four of them had urinary tract stones and their urine samples grew U. urealyticum, three of these patients were schistosomal. It is concluded that a high cure rate [89%] could be achieved by repeating the doxycycline course. Patients with urinary stones should be managed operatively before successful doxycycline therapy